198 related articles for article (PubMed ID: 25738301)
1. The C-terminal sequence of IFITM1 regulates its anti-HIV-1 activity.
Jia R; Ding S; Pan Q; Liu SL; Qiao W; Liang C
PLoS One; 2015; 10(3):e0118794. PubMed ID: 25738301
[TBL] [Abstract][Full Text] [Related]
2. Interferon-Induced Transmembrane Protein 1 Restricts Replication of Viruses That Enter Cells via the Plasma Membrane.
Smith SE; Busse DC; Binter S; Weston S; Diaz Soria C; Laksono BM; Clare S; Van Nieuwkoop S; Van den Hoogen BG; Clement M; Marsden M; Humphreys IR; Marsh M; de Swart RL; Wash RS; Tregoning JS; Kellam P
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567988
[TBL] [Abstract][Full Text] [Related]
3. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
Yu J; Liu SL
Viruses; 2018 Aug; 10(8):. PubMed ID: 30087232
[TBL] [Abstract][Full Text] [Related]
4. Functional Heterogeneity of Mammalian IFITM Proteins against HIV-1.
Marziali F; Delpeuch M; Kumar A; Appourchaux R; Dufloo J; Tartour K; Etienne L; Cimarelli A
J Virol; 2021 Aug; 95(18):e0043921. PubMed ID: 34160255
[TBL] [Abstract][Full Text] [Related]
5. The IFITM proteins inhibit HIV-1 infection.
Lu J; Pan Q; Rong L; He W; Liu SL; Liang C
J Virol; 2011 Mar; 85(5):2126-37. PubMed ID: 21177806
[TBL] [Abstract][Full Text] [Related]
6. Evidence for Paralichthys olivaceus IFITM1 antiviral effect by impeding viral entry into target cells.
Zhu R; Wang J; Lei XY; Gui JF; Zhang QY
Fish Shellfish Immunol; 2013 Sep; 35(3):918-26. PubMed ID: 23850425
[TBL] [Abstract][Full Text] [Related]
7. Topology, Antiviral Functional Residues and Mechanism of IFITM1.
Sun F; Xia Z; Han Y; Gao M; Wang L; Wu Y; Sabatier JM; Miao L; Cao Z
Viruses; 2020 Mar; 12(3):. PubMed ID: 32182730
[TBL] [Abstract][Full Text] [Related]
8. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
[TBL] [Abstract][Full Text] [Related]
9. Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.
Blyth GA; Chan WF; Webster RG; Magor KE
J Virol; 2016 Jan; 90(1):103-16. PubMed ID: 26468537
[TBL] [Abstract][Full Text] [Related]
10. A sorting signal suppresses IFITM1 restriction of viral entry.
Li K; Jia R; Li M; Zheng YM; Miao C; Yao Y; Ji HL; Geng Y; Qiao W; Albritton LM; Liang C; Liu SL
J Biol Chem; 2015 Feb; 290(7):4248-59. PubMed ID: 25527505
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 mutates to evade IFITM1 restriction.
Ding S; Pan Q; Liu SL; Liang C
Virology; 2014 Apr; 454-455():11-24. PubMed ID: 24725927
[TBL] [Abstract][Full Text] [Related]
12. The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.
Wang Y; Pan Q; Ding S; Wang Z; Yu J; Finzi A; Liu SL; Liang C
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100616
[TBL] [Abstract][Full Text] [Related]
13. IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters.
Verma S; Chen YC; Marin M; Gillespie SE; Melikyan GB
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140631
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylation on conserved and nonconserved cysteines of murine IFITM1 regulates its stability and anti-influenza A virus activity.
Hach JC; McMichael T; Chesarino NM; Yount JS
J Virol; 2013 Sep; 87(17):9923-7. PubMed ID: 23804635
[TBL] [Abstract][Full Text] [Related]
15. Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.
Wang B; Lam TH; Soh MK; Ye Z; Chen J; Ren EC
Front Immunol; 2018; 9():1193. PubMed ID: 29904383
[TBL] [Abstract][Full Text] [Related]
16. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters.
Pluymers W; Neamati N; Pannecouque C; Fikkert V; Marchand C; Burke TR; Pommier Y; Schols D; De Clercq E; Debyser Z; Witvrouw M
Mol Pharmacol; 2000 Sep; 58(3):641-8. PubMed ID: 10953059
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins.
Chutiwitoonchai N; Hiyoshi M; Hiyoshi-Yoshidomi Y; Hashimoto M; Tokunaga K; Suzu S
Microbes Infect; 2013 Apr; 15(4):280-90. PubMed ID: 23376165
[TBL] [Abstract][Full Text] [Related]
18. Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.
Jobe O; Trinh HV; Kim J; Alsalmi W; Tovanabutra S; Ehrenberg PK; Peachman KK; Gao G; Thomas R; Kim JH; Michael NL; Alving CR; Rao VB; Rao M
J Leukoc Biol; 2016 Jun; 99(6):1089-106. PubMed ID: 26667473
[TBL] [Abstract][Full Text] [Related]
19. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
20. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
